Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA

[1]  C. Winkler,et al.  Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  D. Bowden,et al.  Potential Donor–Recipient MYH9 Genotype Interactions in Posttransplant Nephrotic Syndrome After Pediatric Kidney Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  M C O'Donovan,et al.  A genome-wide association study in 574 schizophrenia trios using DNA pooling , 2009, Molecular Psychiatry.

[4]  Yongmei Liu,et al.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. , 2009, Kidney international.

[5]  M. Leppert,et al.  Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN Study , 2009, American Journal of Nephrology.

[6]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[7]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[8]  Donald W. Bowden,et al.  Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease , 2008, Human Genetics.

[9]  C. Langefeld,et al.  Association Analysis of the Ephrin-B2 Gene in African-Americans with End-Stage Renal Disease , 2008, American Journal of Nephrology.

[10]  Mahboob Rahman,et al.  Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. , 2008, Archives of internal medicine.

[11]  P. Visscher,et al.  Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays , 2008, Nucleic acids research.

[12]  Marta E Alarcón-Riquelme,et al.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci , 2008, Nature Genetics.

[13]  D. Vlahov,et al.  MYH 9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008 .

[14]  Zhi Guo,et al.  In silico-initiated cloning and molecular characterization of cortexin 3, a novel human gene specifically expressed in the kidney and brain, and well conserved in vertebrates. , 2007, International journal of molecular medicine.

[15]  John V Pearson,et al.  Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study , 2007, Diabetes.

[16]  M. Skolnick,et al.  Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis , 2007, Genes and Immunity.

[17]  D. Bowden,et al.  Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. , 2005, Kidney international.

[18]  Pierre R. Bushel,et al.  Systematic Variation Normalization in Microarray Data to Get Gene Expression Comparison Unbiased , 2005, J. Bioinform. Comput. Biol..

[19]  C. Langefeld,et al.  A genome scan for all-cause end-stage renal disease in African Americans. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  C. Langefeld,et al.  A genome scan for ESRD in black families enriched for nondiabetic nephropathy. , 2004, Journal of the American Society of Nephrology : JASN.